<DOC>
	<DOCNO>NCT01714856</DOCNO>
	<brief_summary>Study subject screen enrolled study . Subjects house clinical facility le 12 hour pre-dose till least 30 hour post-dose period . After maintain least 10 hour overnight fast Test Reference product administer orally ( per randomization schedule ) subject 240 mL water ambient temperature period train study personnel consume whole standardize high fat non-veg breakfast . The pre-dose ( 0.00 hour ) blood sample collect dose post-dose sample collect 2.00 , 3.00 , 4.00 , 5.00 , 6.00 , 7.00 , 7.50 , 8.00 , 8.50 , 9.00 , 9.50 , 10.00 , 10.50 , 11.00 , 11.50 , 12.00 , 12.50 , 13.00 , 14.00 , 16.00 , 20.00 , 24.00 30.00 hour study period washout period 7 day dose two period . Subjects continuously monitor well i.e. , blood pressure , radial pulse oral temperature check-in , prior drug administration regular interval post dose period . The concentration Ropinirole plasma sample obtain study subject determine use validate LC-MS/MS method . Pharmacokinetic statistical analysis perform obtain drug concentration data , use appropriate software .</brief_summary>
	<brief_title>Bioequivalence Study Ropinirole Hydrochloride CR 2mg Tablets Lupin Limited , India , With REQUIP XL GlaxoSmithKline Research Triangle Park , Healthy , Adult , Male , Subjects Under Fed Conditions</brief_title>
	<detailed_description />
	<mesh_term>Ropinirole</mesh_term>
	<criteria>. Availability volunteer entire study period willingness adhere protocol requirement evidence write informed consent form ( ICF ) duly sign volunteer . ii . Healthy human male subject 1845 year Weighing least 50 kg body mass index ( BMI ) 18 kg/m2 less equal 25 kg/m2 ( accord formula BMI = weight ( kg ) / [ height ( ) ] 2 ) . iii . Subjects evidence underlie disease screen medical history whose physical examination perform within 14 day prior commencement study . iv . Subjects whose screen laboratory value within normal limit consider physician/Principal Investigator clinical significance . v. Light , non exsmokers . Light smoker define someone smoking 10 cigarette less per day , exsmokers define someone completely stop smoke least 3 month . History presence significant : I . History hypersensitivity idiosyncratic reaction Ropinirole related product . II . Cardiovascular , pulmonary , hepatic , renal , hematological , gastrointestinal , endocrine , immunologic , dermatologic , musculoskeletal , neurological psychiatric disease . III . Alcohol dependence , alcohol abuse drug abuse within past one year . IV . Moderate heavy smoking ( &gt; 10 cigarettes/day ) consumption tobacco product . V. History difficulty swallow VI . Clinically significant illness within 4 week start study VII . Asthma , urticaria allergic type reaction take medication . Blood loss/donation 350 mL within 3 month prior study dose difficulty donate blood . Participation another clinical study involve donation blood , within precede 90 day study start . Subjects : i. Systolic blood pressure le 90 mm Hg 140 mm Hg ii . Diastolic blood pressure le 60 mm Hg 94 mm Hg . Minor deviation ( 13 mm Hg ) checkin may acceptable discretion physician /investigator . iii . Pulse rate 50/min . 105/min . Any waiver inclusion exclusion criterion must approve documented qualify investigator sponsor casebycase basis .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>